Inari Medical, Inc. (NASDAQ: NARI) reported Q2 EPS of ($0.54), $0.35 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $145.8 million versus the consensus estimate of $143.77 million.

GUIDANCE:

Inari Medical, Inc. sees FY2024 revenue of $594.5-604.5 million, versus the consensus of $598.7 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.